Palfrey D, Cook P J, Smythe J A, Lip G Y, Hine A V
Pharmaceutical Sciences Research Institute, Aston University, Birmingham, UK.
Mol Pathol. 1999 Oct;52(5):289-94. doi: 10.1136/mp.52.5.289.
To investigate multiple techniques for the preparation of solid tissue for polymerase chain reaction (PCR) analysis, and to identify the most simple techniques for routine use in the laboratory.
Techniques for the preparation of arterial tissue samples including homogenisation, ultrafiltration, and treatments involving proteinase K, Gene Clean, lectin, and Fe3+ specific chelators were evaluated using the PCR to amplify both Chlamydia pneumoniae and human DNA.
Treatment with either Gene-Clean or lectin and the Fe3+ specific chelator deferoxamine mesylate removed PCR inhibitors from tissue homogenates. Homogenisation followed by GeneClean treatment resulted in the amplification of C pneumoniae DNA from within a section of atherosclerotic carotid artery, implying that C pneumoniae elementary bodies had been disrupted. In eight further clinical samples from patients not known to have C pneumoniae infection, human DNA was amplified and no cross contamination was observed between samples. These samples contained no evidence of C pneumoniae by PCR.
A simple preparation of solid tissue for PCR analysis, involving homogenisation followed by GeneClean treatment has been developed, and is effective for the amplification of both C pneumoniae and human DNA.
研究用于聚合酶链反应(PCR)分析的固体组织制备的多种技术,并确定实验室常规使用的最简单技术。
使用PCR扩增肺炎衣原体和人类DNA,评估包括匀浆、超滤以及涉及蛋白酶K、基因清洁法、凝集素和Fe3+特异性螯合剂的处理等动脉组织样本制备技术。
用基因清洁法或凝集素以及Fe3+特异性螯合剂甲磺酸去铁胺处理可从组织匀浆中去除PCR抑制剂。匀浆后进行基因清洁法处理可从一段动脉粥样硬化颈动脉中扩增出肺炎衣原体DNA,这意味着肺炎衣原体原体已被破坏。在另外8例未知有肺炎衣原体感染的患者临床样本中,扩增出了人类DNA,且未观察到样本间的交叉污染。通过PCR这些样本未显示有肺炎衣原体的迹象。
已开发出一种用于PCR分析的简单固体组织制备方法,即匀浆后进行基因清洁法处理,该方法对肺炎衣原体和人类DNA的扩增均有效。